Curaderm BEC5 has met all the necessary requirements for its registration by health authorities. The following major drug development phases and milestones have been obtained:

• Research
• Pre-clinical studies
• Investigational New Drug (IND) application
• Phase I to IV clinical trials
• Application and receipt of a New Drug application (NDA) approval

Click here for a synopsis on the development phases and milestones of Curaderm BEC5.

(Research, Pre-Clinical and Phases I to IV Clinical Trials Establish Curaderm BEC5 as the Treatment of Choice for Non Melanoma Skin Cancers)

Additional dermatological products have been through rigorous Research and Development and these are soon to be made available to the public.